DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Anti-Infective AgentsAnti-Infective Agents
  5. /HSVHSV
  6. /NetivudineNetivudine
Chemical structure of CAS 84558-93-0

Netivudine

In Stock•Starting at $135 for 1 mg
CAS No.84558-93-0
MDL No.N/A
MFC12H14N2O6
MW282.25
InChI KeyQLOCVMVCRJOTTM-SDNRWEOFSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$135In Stock
5 mgTo Be Confirmed$339In Stock
10 mgTo Be Confirmed$484In Stock
25 mgTo Be Confirmed$730In Stock
50 mgTo Be Confirmed$979In Stock
100 mgTo Be Confirmed$1331In Stock
200 mgTo Be Confirmed$1761In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.84558-93-0
Product NameNetivudine
Heavy Atom Count20Rotatable Bond Count2
Atom Stereo Count4Bond Stereo Count0
HBA7HBD4
TPSA124.780 ŲCharge0
Exact Mass282.08519Complexity667.00
pKa7.130XLogP-2.480

Related Articles

Studies related to this compound and its mechanism of action

Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents.

Antiviral chemistry & chemotherapy • Vol. 9, Issue 3 • 1998
PMID: 9875402DOI: 10.1177/095632029800900304

Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

Antiviral research • Vol. 35, Issue 3 • 1997
PMID: 9298756DOI: 10.1016/s0166-3542(97)00026-0

Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.

The Journal of antimicrobial chemotherapy • Vol. 37, Issue 3 • 1996
PMID: 9182115DOI: 10.1093/jac/37.3.583

Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology • Vol. 14, Issue 4 • 1995
PMID: 7649195DOI: 10.1007/BF02116525

Documentation

Similar Products

  • 5-(1-Propynyl)-2'-deoxyuridine

    CAS No.84558-94-1

  • Sorivudine

    CAS No.77181-69-2

  • 5-Fluorouridine

    CAS No.316-46-1

  • 5-Hydroxymethyl xylouridine

    CAS No.52448-09-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact